# Is there a role of lipid-lowering therapies in the management of fatty liver disease?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/is-there-a-role-of-lipid-lowering-therapies-in-the-management-of-fatty-liver/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ismini Tzanaki,Aris P. Agouridis,Michael S. Kostapanos |
| Citations | 26 |
| DOI | 10.4254/wjh.v14.i1.119 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://doi.org/10.4254/wjh.v14.i1.119 |
| OpenAlex ID | https://openalex.org/W4205348745 |
| PMID | 35126843 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Ismini Tzanaki](https://scholariq.org/researchers/ismini-tzanaki/)

## Paper primary topic

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Paper topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.